ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation for prostate cancer: same hormone therapy, fewer sessions?
Disease control OngoingThis study compares two types of radiation therapy for men with high-risk prostate cancer that has not spread. One group gets standard radiation (38 sessions over 8 weeks) and the other gets a shorter course (5 sessions over 5 weeks). Both groups also receive hormone therapy. The…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: CCTU • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Smarter hormone therapy aims to control advanced prostate cancer with fewer side effects
Disease control OngoingThis study tests a new way of giving hormone therapy for stage IV prostate cancer that has not yet stopped responding to hormones. Instead of continuous treatment, the therapy is given in cycles based on PSA levels. The goal is to keep the cancer under control while reducing side…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Prostate cancer patients may regain testosterone after drug combo
Disease control OngoingThis study looks at whether testosterone levels return to normal after two years of treatment with relugolix and darolutamide in men with hormone-sensitive prostate cancer. About 33 participants will take the drugs for two years, then stop to see if their testosterone recovers. T…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Atish Choudhury, MD • Aim: Disease control
Last updated May 07, 2026 18:40 UTC